Skip to content
10-K

Annual Report

PANDION THERAPEUTICS, INC.

0001564590-21-012895

← back to feed
Filed
Mar 12, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2020 · Mar 12, 2021 29.52M sh
Capex FY 2020 · Dec 31, 2020 $2.79M
Capex FY 2020 · Dec 31, 2019 $635K
Operating Cash Flow FY 2020 · Dec 31, 2020 −$34.99M
Operating Cash Flow FY 2020 · Dec 31, 2019 −$13.43M
Cash And Equivalents FY 2020 · Dec 31, 2020 $219.89M
Cash And Equivalents FY 2020 · Dec 31, 2019 $15.97M
Current Liabilities FY 2020 · Dec 31, 2020 $8.86M
Current Liabilities FY 2020 · Dec 31, 2019 $7.03M
Total Liabilities FY 2020 · Dec 31, 2020 $13.13M
Total Liabilities FY 2020 · Dec 31, 2019 $16.84M
Current Assets FY 2020 · Dec 31, 2020 $223.94M
Current Assets FY 2020 · Dec 31, 2019 $19.97M
Total Assets FY 2020 · Dec 31, 2020 $227.86M
Total Assets FY 2020 · Dec 31, 2019 $21.02M
Sga Expense FY 2020 · Dec 31, 2020 $12.8M
Sga Expense FY 2020 · Dec 31, 2019 $5.01M
Rd Expense FY 2020 · Dec 31, 2020 $33.91M
Rd Expense FY 2020 · Dec 31, 2019 $18.18M
Net Income FY 2020 · Dec 31, 2020 −$38.11M
Net Income FY 2020 · Dec 31, 2019 −$21.88M
Operating Income FY 2020 · Dec 31, 2020 −$37.93M
Operating Income FY 2020 · Dec 31, 2019 −$22.22M
Revenue FY 2020 · Dec 31, 2020 $8.78M
Revenue FY 2020 · Dec 31, 2019 $967K